These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9522012)

  • 21. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroretinography in psychiatry: A systematic literature review.
    Youssef P; Nath S; Chaimowitz GA; Prat SS
    Eur Psychiatry; 2019 Oct; 62():97-106. PubMed ID: 31553929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone in treatment-refractory chronic alcohol hallucinosis.
    Soyka M; Wegner U; Moeller HJ
    Pharmacopsychiatry; 1997 Jul; 30(4):135-6. PubMed ID: 9271781
    [No Abstract]   [Full Text] [Related]  

  • 24. Switching between clozapine and risperidone treatment.
    Gardner DM; Baldessarini RJ; Benzo J; Zarate CA; Tohen M
    Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773
    [No Abstract]   [Full Text] [Related]  

  • 25. Cocaine craving: an evaluation across treatment phases.
    Bordnick PS; Schmitz JM
    J Subst Abuse; 1998; 10(1):9-17. PubMed ID: 9720002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing.
    Borison RL
    Clin Ther; 1996; 18(4):592-607; discussion 591. PubMed ID: 8879889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone-induced hepatotoxicity in a patient addicted to synthetic cannabinoid.
    Saglam O; Bahsi R; Akkoca Y; Filik L
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):360-1. PubMed ID: 26825144
    [No Abstract]   [Full Text] [Related]  

  • 28. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manic and psychotic symptoms following risperidone withdrawal in a schizophrenic patient.
    Lane HY; Chang WH
    J Clin Psychiatry; 1998 Nov; 59(11):620-1. PubMed ID: 9862609
    [No Abstract]   [Full Text] [Related]  

  • 30. Risperidone and withdrawal dyskinesia.
    Lore C
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941. PubMed ID: 10939219
    [No Abstract]   [Full Text] [Related]  

  • 31. Steroid-induced psychosis treated with risperidone.
    DeSilva CC; Nurse MC; Vokey K
    Can J Psychiatry; 2002 May; 47(4):388-9. PubMed ID: 12025444
    [No Abstract]   [Full Text] [Related]  

  • 32. Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder.
    Kaplan GB; McRoberts RL; Smokler HJ
    J Clin Psychopharmacol; 2004 Oct; 24(5):574-5. PubMed ID: 15349029
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.
    Akerele E; Levin FR
    Am J Addict; 2007; 16(4):260-8. PubMed ID: 17661193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid monoamine metabolites in cocaine patients: no relationship to cue-induced craving.
    Roy A; Berman J; Gonzalez B; Roy M
    J Psychopharmacol; 2002 Sep; 16(3):227-9. PubMed ID: 12236629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic medications for cocaine dependence.
    Amato L; Minozzi S; Pani PP; Davoli M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006306. PubMed ID: 17636840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocaine Craving Questionnaire: assessing craving among cocaine users in Brazil.
    da Silveira DX; Fernandes M; Silveira ED; Jorge MR
    Psychiatry Res; 2006 Jun; 142(2-3):257-9. PubMed ID: 16624420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric properties of the Spanish version of the Cocaine Selective Severity Assessment to evaluate cocaine withdrawal in treatment-seeking individuals.
    Pérez de los Cobos J; Trujols J; Siñol N; Vasconcelos e Rego L; Iraurgi I; Batlle F
    J Subst Abuse Treat; 2014 Sep; 47(3):189-96. PubMed ID: 25012551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.
    Stuyt EB; Sajbel TA; Allen MH
    Am J Addict; 2006; 15(2):166-73. PubMed ID: 16595355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical implications of clozapine discontinuation: report of an NIMH workshop.
    Shore D; Matthews S; Cott J; Lieberman JA
    Schizophr Bull; 1995; 21(2):333-8. PubMed ID: 7543218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.